Participants also had lower levels of natural anticoagulants like antithrombin, protein C, and protein S. These changes suggest a higher risk for thrombosis that increases with higher doses of E2 and blood levels of E2, especially in women who are in late postmenopause. This evidence concerns the gene PROS1 and deep vein thrombosis.